Search Results - "Holuba, N"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    G.O.18 by Darras, B, Chiriboga, C, Swoboda, K, Iannaccone, S, Montes, J, Castro, D, Holuba, N, Raush, N, Visyak, N, Dunaway, S, Trussell, D, Pasternak, A, Neilson, L, Vivo, D. De, McGuire, D, Norris, D, Alexander, K, Bennett, C.F, Bishop, K

    Published in Neuromuscular disorders : NMD (01-10-2014)
    “…This open-label, multiple ascending-dose study was conducted to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pediatrics-1 Spinal Muscular Atrophy Type I: Cases of Normal Cognitive Function Despite having Limited Motor Function and Physical-Environmental Interaction by Leaffer, E, Hinton, V, Salazar, R, Montes, J, Young, S Dunaway, La, N Holuba, De Vivo, D

    Published in Archives of clinical neuropsychology (01-09-2015)
    “…Objective: To examine cognitive development in children with Spinal Muscular Atrophy Type 1 (SMA 1 ), a population with extremely limited motor function. SMA…”
    Get full text
    Journal Article
  4. 4

    G.O.18: Results of a phase 2 study of ISIS-SMNRx in children with spinal muscular atrophy by Darras, B., Chiriboga, C., Swoboda, K., Iannaccone, S., Montes, J., Castro, D., Holuba, N., Raush, N., Visyak, N., Dunaway, S., Trussell, D., Pasternak, A., Neilson, L., Vivo, D. De, McGuire, D., Norris, D., Alexander, K., Bennett, C.F., Bishop, K.

    Published in Neuromuscular disorders : NMD (01-10-2014)
    “…This open-label, multiple ascending-dose study was conducted to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of…”
    Get full text
    Journal Article
  5. 5
  6. 6